U.S. Ambulatory Surgery Centers Market Size, Share, Report, 2033
The U.S. ambulatory surgery center market size was estimated at USD 38.67 billion in 2023 and is projected to hit around USD 69.91 billion by 2033, growing at a CAGR of 6.1% during the forecast period from 2024 to 2033.
Key Takeaways:
U.S. Ambulatory Surgery Center Market Growth
The U.S. ambulatory surgery center devices market size was estimated at USD 24.0 billion in 2022 and is anticipated to grow at a CAGR of 9.16% from 2023 to 2030. Market growth can be attributed to rising investment in Ambulatory surgery centers (ASCs) and favorable reimbursement for services at ambulatory surgery centers in the U.S. In January 2022, the CMS changed eligibility for Medicare reimbursement by removing the criteria of compulsory inpatient procedures at ambulatory surgery centers, allowing reimbursement for outpatient services. Favorable reimbursement for surgical procedures is driving market growth.
The ambulatory services have positively impacted the U.S. healthcare system, making healthcare more accessible, efficient, and cost-effective for patients and providers alike. The number of inpatient admissions has significantly decreased in the past years due to the shifting of procedures toward ASCs. In the U.S., more than 65% of surgeries are performed in ASCs. This is primarily due to high inpatient hospitalization costs and the rise in adoption of advanced technologies by ASCs, enabling rapid & cost-effective treatment provision. Growing pressure from payers and Medicare has also increased the number of people opting for diagnostic tests in nearby ambulatory community care units, not city hospitals.
More people have been getting outpatient surgeries at ambulatory surgery centers (ASCs) in recent years. These centers are popular because they cost less than other places for orthopedic surgeries. A study published in March 2022 found that between 2013 and 2018, the number of orthopedic surgeries performed at ASCs increased from 31% to 34%. The study also showed that there was a small yearly increase in the use of ASCs for specific surgeries and it is becoming a more popular choice for outpatient surgeries, especially for outpatient surgical procedures.
In the last ten years, there has been a growing demand for ambulatory surgery centers, particularly multi-specialty centers. This is partly due to the increasing elderly population, which may require more surgical procedures. A recent report by OR Manager, based on CMS statistics from January 2020, found that 57 million surgical procedures were performed in the U.S. that year. Less than 20% of these procedures were done in outpatient hospital facilities, indicating a shift in demand toward ambulatory surgery centers.
The COVID-19 pandemic had a high impact on the market. The U.S. government introduced guidelines for ambulatory surgery centers in response to the pandemic. In March 2020, the Center for Medicare & Medicaid Services recommended complete halts on nonessential surgery. This resulted in huge financial losses for ambulatory surgery centers, as the majority of revenue-generating surgeries performed at these centers were nonessential. However, there was a positive impact on the demand for ambulatory surgery centers. Patients preferred ambulatory surgery centers due to the lower risk of infection and lower surgery cost than hospitals.
U.S. Ambulatory Surgery Center Market Report Scope
| Report Attribute | Details |
| Market Size in 2024 | USD 41.03 Billion |
| Market Size by 2033 | USD 69.91 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 6.1% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Specialty, ownership, center type, device type, region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Envision Healthcare Corporation; Tenet Healthcare Corporation; Mednax Services, Inc.; TeamHealth; UnitedHealth Group; Quorum Health; Surgery Partners; Community Health Systems, Inc.; SurgCenter; Prospect Medical Systems; Edward-Elmhurst Health; MCKESSON CORPORATION, BD, Koninklijke Philips N.V.; 3M; Olympus America; Zimmer Biomet; GE HealthCare; Abbott; Medtronic; Henry Schein, Inc. |
Specialty Insights
Based on specialty, the market is segmented into orthopedics, cardiology, respiratory, pain management/spinal injections, gastroenterology, ophthalmology, plastic surgery, otolaryngology, obstetrics/gynecology, dental, podiatry, and others. The orthopedics segment accounted for the largest market share of 12.1% in 2023. This can be attributed to the improving diagnostic methods & imaging technologies in orthopedic surgeries and constant developments by the market players in this segment.
In February 2023, Spire Orthopedic Partners entered into a partnership agreement with the Orthopedic Associates of Dutchess County, making Spire one of the biggest orthopedic platforms in the U.S. This would help the company better serve the existing patients and meet the growing demand.
The otolaryngology segment is expected to witness the fastest growth during the forecast period, owing to patients' increasing adoption of ASCs for their Ear, Nose, and Throat (ENT) surgery. In the U.S. around 9% of the total otolaryngology cases are performed in ASCs. Thus, an increasing number of patients with Otolaryngology is anticipated to drive market growth.
Ownership Insights
Based on ownership, the market is segmented into physician-owned, hospital-owned, and corporate-owned. The physician-owned segment accounted for the largest market share of 23.19% in 2023. This can be attributed to its advantages, such as exclusively focusing on a small number of procedures in a single setting and the capability to bring concerns directly to the physicians who have proper knowledge about every patient’s case.
Ambulatory surgery centers offer maximum professional control over the clinical setting and the standard of patient care. Some of these factors are responsible for contributing to the rise in patient footfall toward physician-owned ambulatory surgical centers for performing their procedures, thereby driving the market growth.
The hospital-owned segment is expected to witness the fastest growth during the forecast period, owing to the migration of patients from inpatient hospital settings to hospital-owned ASCs. Furthermore, strategic initiatives undertaken by key players increase their market share by acquiring physician offices and outpatient facilities. For instance, In February 2022, Mayo Clinic announced a USD 432 million expansion in Jacksonville, Florida, which will upgrade an existing facility with 121 inpatient beds. This investment is expected to drive market growth.
Center Type Insights
Based on center type, the market is segmented into single-specialty and multi-specialty. The single-specialty segment accounted for the largest market share of 23.17% in 2023. This can be attributed to the presence of a large number of single-specialty ASCs in the U.S. According to the Report to the Congress: Medicare Payment Policy, the number of single-specialty ambulatory surgical centers in the U.S. was more than 2,890 in 2017. They offer patients a more convenient and cost-effective alternative to hospital-based care, and provide more specialized care, as they focus exclusively on one type of surgery.
Surgeries performed in single-specialty ASCs include cataract surgery, hernia repair, joint replacements, colonoscopies, and other minimally invasive procedures. These facilities must comply with strict regulations and standards for patient safety & quality of care. Moreover, these centers are likely to have a high reimbursement per procedure.
The multi-specialty segment is expected to witness the fastest growth during the forecast period, owing to a comprehensive and patient-centered approach to surgical care, providing a range of services under one roof and helping streamline patients' healthcare experience. Unlike single-specialty ASCs, a multi-specialty center has 50 to 100 surgeons. Thus, the benefits associated with multi-specialty ASCs are expected to drive market growth.
Region Insights
Based on region, the market is segmented into Southeast, West, Midwest, Northeast, and Southwest. The Southeast region accounted for the largest revenue share of 11.7% in 2023. This can be attributed to the increasing popularity of outpatient surgery; there has been the creation of a significant number of physician-owned ASCs in the region. In September 2022, Intermountain Healthcare opened a new state-of-the-art ambulatory surgery center (ASC) in St. George. This new ASC is expected to provide surgical services in a convenient, patient-centered environment. Patients can expect to receive high-quality care in a facility with the latest medical technology and equipment.
Several developments in the West region have been contributing to its growth. For instance, in December 2022, USA Health received approval to build a multi procedure ASC on its West Mobile campus. It would make it easier for those living around the campus to obtain outpatient surgery services supported by academic medicine.
The Midwest region is expected to witness the fastest growth during the forecast period, owing to increasing investment in the region for developing new outpatient healthcare facilities. For instance, in January 2020, the University of Illinois Hospital and Health Science System plans to construct a new outpatient building on its main hospital campus on the West Side of Chicago. The proposed six-story building is expected to cost USD 191 million and provide additional outpatient services to patients, thereby driving market growth.
Key Companies & Market Share Insights
The market is moderately fragmented. Key players are adopting several strategies, including launching new centers and raising funds from investors, to strengthen their position in the market. For instance, in February 2023, the University of Rochester Medical Center Rochester opened the country’s first Orthopedics and Physical Surgery Center in Henrietta. Some prominent players in the U.S. ambulatory surgery center market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Ambulatory Surgery Center market.
By Specialty
By Ownership
By Center Type
By Device Type
By Regional
Chapter 1 U.S. Ambulatory Surgery Center Market: Report Scope & Research Methodology
1.1 Market Segmentation
1.1.1 Segment Definition
1.1.1.1 Application
1.1.1.2 Ownership
1.1.1.3 Center Type
1.1.1.4 Device Type
1.1.1.5 Region
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
1.3.1 Information procurement
1.3.2 Purchased Database
1.3.3 nova one advisor. Internal Database
1.3.4 Secondary Sources
1.3.5 Primary Research
1.3.6 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Commodity Flow Analysis
1.6 List of Secondary Sources
1.7 List of Abbreviations
Chapter 2 U.S. Ambulatory Surgery Center Market: Research Objectives
2.1 Objective - 1
2.2 Objective - 2
2.3 Objective - 3
Chapter 3 U.S. Ambulatory Surgery Center Market: Executive Summary
3.1 Market Snapshot
3.2 Segment Outlook
3.3 Competitive Scenario
Chapter 4 U.S. Ambulatory Surgery Center Market - Industry Outlook
4.1 Market Lineage Outlook
4.1.1 Parent market outlook
4.1.2 Related Market Outlook
4.2 Market Dynamics
4.2.1 Market driver analysis
4.2.1.1 Lower healthcare expenditure at ambulatory surgery center compared to hospitals
4.2.1.2 Favorable reimbursement for ambulatory surgery center
4.2.1.3 Lower risk of infection at ASC compared to hospitals
4.2.2 Market restraint analysis
4.2.2.1 Lower physician to patient ratio in the U.S.
4.2.2.2 Stringent regulations for ambulatory surgery centers in the U.S.
4.2.3 Industry Challenges
4.2.3.1 High physician turnover
4.2.3.2 Hospitals buying ambulatory surgery centers
4.2.4 Industry Opportunities
4.2.4.1 Growing demand for multiprocedure ambulatory surgery centers
4.3 Impact of COVID-19: Qualitative Analysis
4.3.1 During the COVID-19 pandemic
4.3.2 Post pandemic outlook
4.4 Regulatory Scenario & Reimbursement Outlook
4.4.1 Regulatory Scenario
4.4.2 Reimbursement Framework
4.5 Business Environment Analysis Tools
4.5.1 U.S. Ambulatory Surgery Center - Porter’s Five Forces Analysis
4.5.2 U.S. Ambulatory Surgery Center - PESTLE Analysis
Chapter 5 U.S. Ambulatory Surgery Center Market: Specialty Estimates & Trend Analysis
5.1 U.S. Ambulatory Surgery Center Procedure Market: Specialty Segment Dashboard
5.2 Procedure Movement Analysis & Market Share, 2024 - 2033
5.3 U.S. Ambulatory Surgery Center Procedure Market Estimates & Forecasts, By Specialty, 2018 -2030
5.3.1 Orthopedics
5.3.1.1 Orthopedics market, 2021 - 2033
5.3.2 Pain Management/Spinal Injections
5.3.2.1 Pain management/spinal injections market, 2021 - 2033
5.3.3 Gastroenterology
5.3.3.1 Gastroenterology market, 2021 - 2033
5.3.4 Ophthalmology
5.3.4.1 Ophthalmology market, 2021 - 2033
5.3.5 Plastic surgery
5.3.5.1 Plastic surgery market, 2021 - 2033
5.3.6 Otolaryngology
5.3.6.1 Otolaryngology market, 2021 - 2033
5.3.7 Obstetrics/gynecology
5.3.7.1 Obstetrics/gynecology market, 2021 - 2033
5.3.8 Dental
5.3.8.1 Dental market, 2021 - 2033
5.3.9 Podiatry
5.3.9.1 Podiatry market, 2021 - 2033
5.3.9 Cardiology
5.3.9.1 Cardiology market, 2021 - 2033
5.3.10 Respiratory
5.3.10.1 Respiratory market, 2021 - 2033
5.3.11 Others
5.3.11.1 Other specialties market, 2021 - 2033
Chapter 6 U.S. Ambulatory Surgery Center Market: Ownership Estimates & Trend Analysis
6.1 U.S. Ambulatory Surgery Center Market: Ownership Segment Dashboard
6.2 Ownership Movement Analysis & Market Share, 2024 - 2033
6.3 U.S. Ambulatory Surgery Center Market Estimates & Forecasts, By Ownership, 2021 - 2033
6.3.1 Physician-owned
6.3.1.1 Physician-owned ambulatory surgery center market, 2021 - 2033
6.3.2 Hospital-owned
6.3.2.1 Hospital-owned ambulatory surgery center market, 2021 - 2033
6.3.3 Corporate owned
6.3.3.1 Corporate-owned ambulatory surgery center market, 2021 - 2033
Chapter 7 U.S. Ambulatory Surgery Center Market: Center Type Estimates & Trend Analysis
7.1 U.S. Ambulatory Surgery Center Market: Center Type Segment Dashboard
7.2 Center Type Movement Analysis & Market Share, 2024 - 2033
7.3 U.S. Ambulatory Surgery Center Market Estimates & Forecasts, By Center Type, 2018 -2030
7.3.1 Single-specialty
7.3.1.1 Single-specialty ambulatory surgery center market, 2021 - 2033
7.3.2 Multi-speciaty
7.3.2.1 Multi-specialty ambulatory surgery center market, 2021 - 2033
Chapter 8 U.S. Ambulatory Surgery Center Device Market: Device Type Estimates & Trend Analysis
8.1 U.S. Ambulatory Surgery Center Device Market: Specialty Segment Dashboard
8.2 Device Type Movement Analysis & Market Share, 2024 - 2033
8.3 U.S. Ambulatory Surgery Center Devices Market Estimates & Forecasts, By Specialty, 2021 - 2033
8.3.1 Cardiology
8.3.1.1 Cardiology devices market, 2021 - 2033
8.3.2 Orthopedic
7.3.2.1 Orthopedic devices market, 2021 - 2033
8.3.3 Pain Management/Spinal Injections
7.3.3.1 Pain management/spinal injections devices market, 2021 - 2033
8.3.4 Opthalmology
8.3.4.1 Opthalmology devices market, 2021 - 2033
8.3.5 Respiratory
8.3.5.1 Respiratory devices market, 2021 - 2033
8.3.6 Plastic Surgery
8.3.6.1 Plastic surgery devices market, 2021 - 2033
8.3.7 Spinal Surgery
8.3.7.1 Spinal surgery devices market, 2021 - 2033
8.3.8 Others
8.3.8.1 Other devices market, 2021 - 2033
Chapter 9 U.S. Ambulatory Surgery Center Market: Regional Estimates & Trend Analysis
9.1 U.S. Ambulatory Surgery Center Market: Region Segment Dashboard
9.2 Region Movement Analysis & Market Share, 2024 - 2033
9.3 U.S. Ambulatory Surgery Center Market Estimates & Forecasts, By Region, 2021 - 2033
9.3.1 Southeast
9.3.1.1 Southeast ambulatory surgery center market, 2021 - 2033
9.3.2 West
9.3.2.1 West ambulatory surgery center market, 2018-2033
9.3.3 Midwest
9.3.3.1 Midwest ambulatory surgery center market, 2021 - 2033
9.3.4 Northeast
9.3.4.1 Northeast ambulatory surgery center market, 2021 - 2033
9.3.5 Southwest
9.3.5.1 Southwest ambulatory surgery center market, 2021 - 2033
Chapter 10 U.S. Ambulatory Surgery Center Market Competitive Landscape
10.1 Participant Categorization
10.2 Company Market Position Analysis
10.3 Strategy Mapping
10.3.1 Expansion
10.3.2 Partnerships
10.3.3 Acquisition
10.3.4 Collaborations
10.3.5 Others
10.4. Service Providers Company Profiles
10.4.1 Envision Healthcare Corporation
10.4.1.1. Overview
10.4.1.2. Financial Performance
10.4.1.3. Service Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Tenet Healthcare Corporation
10.4.2.1. Overview
10.4.2.2. Financial Performance
10.4.2.3. Service Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Mednax Services, Inc.
10.4.3.1. Overview
10.4.3.2. Financial Performance
10.4.3.3. Service Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. TeamHealth
10.4.4.1. Overview
10.4.4.2. Financial Performance
10.4.4.3. Service Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. UnitedHealth Group
10.4.5.1. Overview
10.4.5.2. Financial Performance
10.4.5.3. Service Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Quorum Health
10.4.6.1. Overview
10.4.6.2. Financial Performance
10.4.6.3. Service Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Surgery Partners
10.4.7.1. Overview
10.4.7.2. Financial Performance
10.4.7.3. Service Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Community Health Systems, Inc.
10.4.8.1. Overview
10.4.8.2. Financial Performance
10.4.8.3. Service Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. SurgCenter
10.4.9.1. Overview
10.4.9.2. Financial Performance
10.4.9.3. Service Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Prospect Medical Systems
10.4.10.1. Overview
10.4.10.2. Financial Performance
10.4.10.3. Service Benchmarking
10.4.10.4. Strategic Initiatives
10.4.11. Edward-Elmhurst Health
10.4.11.1. Overview
10.4.11.2. Financial Performance
10.4.11.3. Service Benchmarking
10.4.11.4. Strategic Initiatives
10.5. Suppliers Company Profiles
10.5.1 MCKESSON CORPORATION
10.5.1.1. Overview
10.5.1.2. Financial Performance
10.5.1.3. Service Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. BD
10.5.2.1. Overview
10.5.2.2. Financial Performance
10.5.2.3. Service Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Koninklijke Philips N.V.
10.5.3.1. Overview
10.5.3.2. Financial Performance
10.5.3.3. Service Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. 3M
10.5.4.1. Overview
10.5.4.2. Financial Performance
10.5.4.3. Service Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. Olympus America
10.5.5.1. Overview
10.5.5.2. Financial Performance
10.5.5.3. Service Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. GE HealthCare
10.5.6.1. Overview
10.5.6.2. Financial Performance
10.5.6.3. Service Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. Abbott
10.5.7.1. Overview
10.5.7.2. Financial Performance
10.5.7.3. Service Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. Medtronic
10.5.8.1. Overview
10.5.8.2. Financial Performance
10.5.8.3. Service Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Zimmer Biomet
10.5.9.1. Overview
10.5.9.2. Financial Performance
10.5.9.3. Service Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Henry Schein, Inc.
10.5.10.1. Overview
10.5.10.2. Financial Performance
10.5.10.3. Service Benchmarking
10.5.10.4. Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers